Systemic Lupus Erythematosus Clinical Trials

A listing of Systemic Lupus Erythematosus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

with Moderna COVID-19 vaccine, Pfizer-BioNTech COVID-19 vaccine, or Janssen COVID-19 vaccine. The study will initially focus on 5 autoimmune diseases: Systemic Lupus Erythematosus

lupus
rheumatism
autoimmune disease
prednisone
SARS
  • 11 views
  • 27 Sep, 2021
  • 5 locations
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection

There is a pandemic in the world by COVID-19. Currently, the pharmacological curative or prophylactic treatments for this infection are not known. Recent studies have suggested that Hydroxy-Chloroquine could be effective in vitro and in vivo against COVID-19. The main objective of this study is to assess in patients with …

  • 0 views
  • 17 Sep, 2021
  • 8 locations
Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)

To assess the pharmacokinetic parameters of anifrolumab in Chinese participants with active systemic lupus erythematosus(SLE).

lupus
anifrolumab
  • 0 views
  • 17 Sep, 2021
  • 4 locations
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or without Active

azathioprine
nephritis
proteinuria
systemic lupus erythematosus
mycophenolate
  • 0 views
  • 26 Sep, 2021
  • 17 locations
Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

This is a multi-center, randomized, double-blind, placebo-controlled study. Study subjects are class III, IV, V, III+V, IV+V lupus nephritis patients, according to ISN/RPS 2003 classification of

prednisone
corticosteroids
urinary sediment
immunosuppressive agents
nephritis
  • 5 views
  • 26 Sep, 2021
  • 1 location
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

systemic sclerosis (SSc) and systemic lupus erythematosis (SLE), two potentially life threatening autoimmune diseases that may response to this therapeutic approach.

lupus
progressive systemic sclerosis
autoimmune disease
  • 0 views
  • 17 Sep, 2021
  • 1 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced Metastatic or Unresectable Cancer

This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's …

neutrophil count
hepatitis c virus
disease or disorder
follicle stimulating hormone
pd-l1
  • 620 views
  • 26 Sep, 2021
  • 30 locations
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Background Bile duct cancer is cancer of the slender tubes of the biliary tract. These tubes carry bile through the liver. Such cancer tumors often have an abnormal or mutated gene. Researchers think a mix of drugs can slow the progression of gene-mutated cancers of the biliary tract. Objective To …

measurable disease
EGFR
KRAS
hydroxychloroquine
cancer
  • 0 views
  • 26 Sep, 2021
  • 1 location
Study of Systemic Lupus Erythematosus

This protocol will evaluate patients with systemic lupus erythematosus (SLE) and their relatives to learn more about how the disease develops and changes over time. It will also study genetic

lupus
apheresis
  • 213 views
  • 26 Sep, 2021
  • 1 location
Investigating Genes in Patients With Polymyositis and Dermatomyositis

rheumatoid arthritis (RA) and systemic lupus (SLE), it is known that changes to the Human Leukocyte Antigen(HLA), as well as certain inflammatory cytokines, are involved in both the development and

lupus
weakness
polymyositis
rash
muscle biopsy
  • 96 views
  • 28 Sep, 2021
  • 1 location